imv inc launches plans to advance clinical development of a vaccine candidate against covid dartmouth nova scotiabusiness wireimv inc nasdaq imv tsx imv a clinicalstage biopharmaceutical company the company or imv today announced that it is advancing the clinical development of a dpxbased vaccine candidate against covid va dartmouth nova scotiabusiness wireimv inc nasdaq imv tsx imv a clinicalstage biopharmaceutical company the company or imv today announced that it is advancing the clinical development of a dpxbased vaccine candidate against covid vaccin  chars
